About Doc Generici
Doc Generici is a Healthcare company based in Milan (Italy) founded in 1996, and was acquired by ICG in April 2019. Generic pharmaceuticals and ophthalmology products are manufactured in Italy. Its chief executive, as recorded, is Gualtiero Pasquarelli. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is DOC Pharma.
Company details
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
Apps and channels of Doc Generici
its YouTube channel DOC Pharma Official has 415 subscribers and 30 videos.
Videos from Doc Generici
The most watched videos on Doc Generici's YouTube channel, DOC Pharma Official (415 subscribers). Click a video to play it here.
More on DOC Pharma Official.
Investors in Doc Generici
Doc Generici has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include CVC, ICG and Charterhouse Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed by Charterhouse Capital Partners. | charterhouse.co.uk | London, United Kingdom | ||
Mezzanine financing and equity investments are provided by CVC. | 1981 | cvc.com | New York, United States | |
ICG is recognized as a global alternative asset manager. | 1989 | icgam.com | London, United Kingdom | |
Pivate equity firm that focuses on investing in healthcare and nutrition companies | merieux-partners.com | Lyon, France |
Investor details for Doc Generici
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Doc Generici
14 people are tracked at Doc Generici (7 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Gualtiero Pasquarelli | CEO & MD | Leadership |
Alberto Villa | CFO | Leadership |
Silvia Lissoni | Technology Transfer Director | Leadership |
Riccardo Zagaria | CEO | Leadership |
Anna Gabriella Ferrari | HR Director | Leadership |
Gaspare Sciaulino | Head Of Business Excellence | Leadership |
Francesco Lischi | Head Of Logistics & Customer Service | Leadership |
Sara Tumiotto | Senior Accountant | Team |
Anna Girola | HR Generalist | Team |
Federico Grassi | Digital Marketing | Team |
Silvia Negri | Product Manager | Team |
Laura Trinca | Product Specialist | Team |
Claudia Corrado | QA Specialist | Team |
Alessia Sammartino | Legal Specialist & Compliance Officer | Team |
Complete people profiles for Doc Generici
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Doc Generici
4 dated milestones of Doc Generici across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Doc Generici is founded.
- Exit Acquired by Charterhouse Capital Partners.
- Exit Acquired by CVC.
- Exit Acquired by ICG.
Web traffic of Doc Generici
Websites that share an audience with Doc Generici (docgenerici.it).
Websites whose visitors overlap most with Doc Generici. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
equivalente.it | equivalente.it | 100% | #403,014 | – | |
chntc.cyc.org.tw | chntc.cyc.org.tw | 94% | – | ||
medapharma.it | medapharma.it | 58% | – | ||
corporate.bracco.com | corporate.bracco.com | 57% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Doc Generici
Complete news archive for Doc Generici
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Doc Generici
Doc Generici was founded in 1996.
Doc Generici is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Gualtiero Pasquarelli is the CEO of Doc Generici, as recorded in our data.
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
Doc Generici has 4 investors. Key investors include CVC, ICG, Charterhouse Capital Partners, and Merieux Equity Partners.
Doc Generici operates through Doc Pharma.
Yes. Doc Generici was acquired by ICG in April 2019.